Dual modulators of 5-HT2A and D3 receptors

Details for Australian Patent Application No. 2008280187 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Roche, Olivier; Steward, Lucinda; Rodriguez Sarmiento, Rosa Maria; Gobbi, Luca; Jaeschke, Georg

Agent Spruson & Ferguson

Pub. Number AU-A-2008280187

PCT Pub. Number WO2009/013212

Priority 07113252.6 26.07.07 EP

Filing date 17 July 2008

Wipo publication date 29 January 2009

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/454 (2006.01)

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2009/013212 Priority application(s): WO2009/013212

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008280193-Powder inhaler

2008280186-New pyrazol derivatives